Genetic deletions in AML and MDS

Best Practice and Research: Clinical Haematology

Volumn 23, Issue 4, 2010, Pages 457-461

  Ebert, Benjamin L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

5q deletion; 5q ; Diamond Blackfan anemia; Haploinsufficiency; MiR 145; Myelodysplastic syndromes (MDS); P53; RPS14

Indexed keywords

MICRORNA; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; BLACKFAN DIAMOND ANEMIA; CHROMOSOME 5Q; CHROMOSOME DELETION; CYTOGENETICS; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HUMAN; KARYOTYPE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RIBOSOME SUBUNIT; TUMOR SUPPRESSOR GENE;

ANEMIA, DIAMOND-BLACKFAN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; ERYTHROPOIESIS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICRORNAS; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; RIBOSOMAL PROTEINS; RNA, NEOPLASM;

EID: 78649920418     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2010.09.006     Document Type: Review

References (24)

1. S. Frohling, and H. Dohner Chromosomal abnormalities in cancer N Engl J Med 359 2008 722 734
2. R. Bejar, and B.L. Ebert The genetic basis of myelodysplastic syndromes Hematol Oncol Clin North Am 24 2010 295 315
3. B.L. Ebert Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer Leukemia 23 2009 1252 1256
4. H. Van Den Berghe, J.J. Cassiman, and G. David Distinct haematological disorder with deletion of long arm of no. 5 chromosome Nature 251 1974 437 438
5. A.A. Giagounidis, U. Germing, and C. Aul Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies Clin Cancer Res 12 2006 5 10
6. J. Boultwood, C. Fidler, and A.J. Strickson Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome Blood 99 2002 4638 4641
7. N. Zhao, A. Stoffel, and P.W. Wang Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map Proc Natl Acad Sci U S A 94 1997 6948 6953
8. S.K. Horrigan, Z.H. Arbieva, and H.Y. Xie Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31 Blood 95 2000 2372 2377
9. T.A. Graubert, M.A. Payton, and J. Shao Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis PLoS One 4 2009 e4583
10. L.P. Gondek, R. Tiu, and C.L. O'Keefe Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML Blood 111 2008 1534 1542
11. S. Heinrichs, R.V. Kulkarni, and C.E. Bueso-Ramos Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics Leukemia 23 2009 1605 1613
12. A. Mohamedali, J. Gaken, and N.A. Twine Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes Blood 110 2007 3365 3373
13. B.L. Ebert, J. Pretz, and J. Bosco Identification of RPS14 as a 5q- syndrome gene by RNA interference screen Nature 451 2008 335 339
14. A. Narla, and B.L. Ebert Ribosomopathies: human disorders of ribosome dysfunction Blood 115 2010 3196 3205
15. J.L. Barlow, L.F. Drynan, and D.R. Hewett A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome Nat Med 16 2010 59 66
16. S. Fumagalli, C.A. Di, and A. Neb-Gulati Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation- dependent mechanism of p53 induction Nat Cell Biol 11 2009 501 508
17. M. Kumar, A. Narla, and A. Nonami Coordinate loss of a microRNA Mir 145 and a protein-coding gene RPS14 cooperate in the pathogenesis of 5q- syndrome [abstract] Blood (ASH Annual Meeting Abstracts) 114 22 2009 Abstract 947
18. D.T. Starczynowski, F. Kuchenbauer, and B. Argiropoulos Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype Nat Med 16 2010 49 58
19. S.W. Lane, S.M. Sykes, and F. Al-Shahrour The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS Blood 115 2010 3489 3497
20. J. Wang, A.A. Fernald, and J. Anastasi Haploinsufficiency of Apc leads to ineffective hematopoiesis Blood 115 2010 3481 3488
21. J.M. Joslin, A.A. Fernald, and T.R. Tennant Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders Blood 110 2007 719 726
22. I.M. Min, G. Pietramaggiori, and F.S. Kim The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells Cell Stem Cell 2 2008 380 391
23. S. Grisendi, R. Bernardi, and M. Rossi Role of nucleophosmin in embryonic development and tumorigenesis Nature 437 2005 147 153
24. S. Wei, X. Chen, and K. Rocha A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide Proc Natl Acad Sci U S A 106 2009 12974 12979